A Leader in Treating AIDS-Related Cancers
BIDMC has been a prominent force in HIV, cancer care and research for
more than 26 years. Our internationally acclaimed team is
experienced in optimizing treatment for AIDS-related malignancies in our
patients who are also undergoing lifelong anti-retroviral therapy (HAART).
BIDMC is one of seven core sites in the
AIDS Malignancy Consortium
(AMC), a National Cancer Institute-funded clinical trials group. The
purpose of the AMC is to develop new treatment strategies for AIDS-related
cancers. Our staff are major enrollers in this multi-institutional
organization with 37 sites worldwide.
Beth Israel Deaconess is a founding member of the Dana-Farber/Harvard
Cancer Center (DF/HCC) - Harvard's National Cancer Institute-designated
comprehensive cancer center. We collaborate extensively on
with the DF/HCC.
Cancer in the HIV Setting
If you have HIV, you are at increased risk for developing lymphoma and
other types of cancer. While improved anti-retroviral therapy has enriched
the quality of life, cancer in the HIV setting is a growing concern. If you have a compromised immune system, tumors
tend to progress faster and certain cancers typically seen in an older
population, such as lymphoma, may occur earlier and with greater frequency. You may not tolerate chemotherapy
and radiation therapy as well as the population at large, and you may
experience side effects from interactions with multiple drug therapies.
Our team of HIV and cancer specialists at BIDMC are highly proficient and
experienced at managing these and other issues associated with HIV and
cancer by anticipating side effects and complications, monitoring your
condition more closely and intervening earlier.
Collaborative, Compassionate Care
BIDMC has a long history of providing supportive, compassionate care for
patients with HIV disease and their loved ones.
Our team of HIV cancer experts work closely to provide a broad spectrum of
services, from topical and local treatment to systemic chemotherapy and
novel therapies under evaluation (clinical trials). We collaborate with the
Division of Infectious Disease
and the Departments of
Psychiatry. We consult with
pathologists, who play a key role in identifying the type and extent of your cancer (if
it has spread), and help guide treatment. Depending on your diagnosis
and symptoms, you may see one of our cancer specialists in
Interventional Radiology, among others.
We were one of the first medical establishments in New England to
specialize in HIV treatment, opening an HIV Clinic in the early 1980s. We
also have an Infectious Disease/Oncology Dysplasia Clinic, which offers
education, screening and treatment of disorders associated with the human
Improving Quality of Life
A hallmark of our service is the warm, personalized and supportive
relationship we strive to establish with with our patients and their families. We offer a broad network
of support services and resources to help you and your family understand
your cancer diagnosis in the setting of HIV, the tests and procedures you
will need, your recovery period, medications, returning home, and much
more. Throughout your treatment and care, you can stay connected with loved
ones through CarePages, our free, personal and private web page service.
CarePages lets you share treatment news with friends and family, and
receive messages of support.
Our goal, always, is to improve the quality of life. Our approach features
collaboration among our leading HIV and cancer experts, shared
decision-making with you and your loved ones, access to state-of-the-art
treatments tailored for you, and long-term and compassionate follow-up care
Treatment decisions for Kaposi's sarcoma, lymphoma, HPV-related cancers and non-AIDS defining cancers are based on the type of symptoms you have
and how extensive your cancer might be. Your personalized treatment plan
may include surgery, medical oncology (chemotherapy and other agents) and/or radiation therapy — separately or in some combination.
You may benefit from standard treatment protocols (guidelines) that improve
the outcome of your particular cancer and symptoms. Or you may qualify for
one of our extensive
clinical trials — research studies that are designed to find better treatments for cancer
patients based on the most updated research from around the country.